{"transactions":[{"id":4638841,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":32144,"kind":"person","name":"Reed Joshua","position":1,"cik":"0001746541","reported_name":"Reed Joshua","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-10-09T22:18:17.000Z","date":"2026-10-08","kind":"exercise","planned":false,"acquired":false,"shares":9164,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026."}],"balance_after":27492,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9164},"source":{"system":"sec-edgar","filing":"0001520262-26-000131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746541/000152026226000131/form4.xml","form_type":"4"}},{"id":4638840,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":32144,"kind":"person","name":"Reed Joshua","position":1,"cik":"0001746541","reported_name":"Reed Joshua","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-09T22:18:17.000Z","date":"2026-10-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":4069,"price":40.11,"value":163207.59,"ownership":{"direct":true},"balance_after":5095,"source":{"system":"sec-edgar","filing":"0001520262-26-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746541/000152026226000131/form4.xml","form_type":"4"}},{"id":4638839,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":32144,"kind":"person","name":"Reed Joshua","position":1,"cik":"0001746541","reported_name":"Reed Joshua","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-10-09T22:18:17.000Z","date":"2026-10-08","kind":"exercise","planned":false,"acquired":true,"shares":9164,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":9164,"source":{"system":"sec-edgar","filing":"0001520262-26-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746541/000152026226000131/form4.xml","form_type":"4"}},{"id":4638838,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":24301,"kind":"person","name":"Whitaker Anne Clem","position":1,"cik":"0001593283","reported_name":"Whitaker Anne Clem","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-10-09T22:16:42.000Z","date":"2026-10-07","kind":"grant","planned":false,"acquired":true,"shares":17998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the stock option award vest in three equal annual installments commencing on 10/7/2027."}],"balance_after":17998,"derivative":{"exercise_price":41.445,"expiration_date":"2036-10-07","underlying":"Ordinary Shares","underlying_shares":17998},"source":{"system":"sec-edgar","filing":"0001520262-26-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593283/000152026226000130/form4.xml","form_type":"4"}},{"id":4638837,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":24301,"kind":"person","name":"Whitaker Anne Clem","position":1,"cik":"0001593283","reported_name":"Whitaker Anne Clem","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-10-09T22:16:42.000Z","date":"2026-10-07","kind":"grant","planned":false,"acquired":true,"shares":7239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 10/7/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 10/7/2027."}],"balance_after":7239,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7239},"source":{"system":"sec-edgar","filing":"0001520262-26-000130","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593283/000152026226000130/form4.xml","form_type":"4"}},{"id":4628831,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-10-02T22:22:22.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":41.03,"value":83455.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":221388,"source":{"system":"sec-edgar","filing":"0001520262-26-000127","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1675905/000152026226000127/form4.xml","form_type":"4"}},{"id":3460,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-09-03T22:32:44.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":48.01,"value":97652.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":223422,"source":{"system":"sec-edgar","filing":"0001520262-26-000120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1675905/000152026226000120/form4.xml","form_type":"4"}},{"id":670911,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":61276,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":670910,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":46.986,"value":422874.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.8269 to $47.3197. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":65389,"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":670909,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":24.59,"value":122950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":74389,"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":685614,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":22900,"kind":"person","name":"Nichols Christian Todd","position":1,"cik":"0001813312","reported_name":"Nichols Christian Todd","relationship":{"officer":true,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-17T22:53:35.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":664,"price":49.6526,"value":32969.3264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/15/2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.61 to $49.79. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":102193,"source":{"system":"sec-edgar","filing":"0001520262-26-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813312/000152026226000116/form4.xml","form_type":"4"}},{"id":685613,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":22900,"kind":"person","name":"Nichols Christian Todd","position":1,"cik":"0001813312","reported_name":"Nichols Christian Todd","relationship":{"officer":true,"officer_title":"SVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-17T22:53:35.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":6912,"price":49.1851,"value":339967.4112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 5/15/2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.6092 to $49.49. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":102857,"source":{"system":"sec-edgar","filing":"0001520262-26-000116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813312/000152026226000116/form4.xml","form_type":"4"}},{"id":692870,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":25365,"kind":"person","name":"Jackson Blair Curtis","position":1,"cik":"0001842348","reported_name":"Jackson Blair Curtis","relationship":{"director":true,"officer":true,"officer_title":"President & CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-08T01:17:06.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":124305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This award was granted in connection with the reporting person's appointment as President and Chief Executive Officer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the stock option shall vest and become exercisable, if at all, in two tranches based upon the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, trading at certain pre-specified levels for 30 consecutive trading days, subject in each case to the reporting person's completion of two years of continuous service (or less, in the event of a change in control) in the role of President and Chief Executive Officer. This award expires ten years from the date of grant."}],"balance_after":124305,"derivative":{"exercise_price":49.61,"expiration_date":"2036-08-05","underlying":"Ordinary Shares","underlying_shares":124305},"source":{"system":"sec-edgar","filing":"0001520262-26-000113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000113/form4.xml","form_type":"4"}},{"id":692869,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":25365,"kind":"person","name":"Jackson Blair Curtis","position":1,"cik":"0001842348","reported_name":"Jackson Blair Curtis","relationship":{"director":true,"officer":true,"officer_title":"President & CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-08T01:17:06.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":93229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This award was granted in connection with the reporting person's appointment as President and Chief Executive Officer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 8/5/2027."}],"balance_after":93229,"derivative":{"exercise_price":49.61,"expiration_date":"2036-08-05","underlying":"Ordinary Shares","underlying_shares":93229},"source":{"system":"sec-edgar","filing":"0001520262-26-000113","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000113/form4.xml","form_type":"4"}},{"id":698632,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-08-03T23:16:59.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":46.72,"expiration_date":"2026-09-14","underlying":"Ordinary Shares","underlying_shares":16524},"source":{"system":"sec-edgar","filing":"0001520262-26-000111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000111/form4.xml","form_type":"4"}},{"id":698631,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-08-03T23:16:59.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":false,"shares":27948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":46.72,"expiration_date":"2026-09-14","underlying":"Ordinary Shares","underlying_shares":27948},"source":{"system":"sec-edgar","filing":"0001520262-26-000111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000111/form4.xml","form_type":"4"}},{"id":698630,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:16:59.000Z","date":"2026-08-03","kind":"sale","planned":false,"acquired":false,"shares":44472,"price":50.348,"value":2239076.256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.07 to $50.70. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":15395,"source":{"system":"sec-edgar","filing":"0001520262-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000111/form4.xml","form_type":"4"}},{"id":698629,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:16:59.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":16524,"price":46.72,"value":772001.28,"ownership":{"direct":true},"balance_after":59867,"source":{"system":"sec-edgar","filing":"0001520262-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000111/form4.xml","form_type":"4"}},{"id":698628,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:16:59.000Z","date":"2026-08-03","kind":"exercise","planned":false,"acquired":true,"shares":27948,"price":46.72,"value":1305730.56,"ownership":{"direct":true},"balance_after":43343,"source":{"system":"sec-edgar","filing":"0001520262-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000111/form4.xml","form_type":"4"}},{"id":698627,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":66276,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698626,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":1252,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":104},"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698625,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":48.58,"value":437220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":69389,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698624,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":24.59,"value":120392.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":78389,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698623,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":104,"price":19.34,"value":2011.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":73493,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698622,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:09:28.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":48.58,"value":98811.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":225456,"source":{"system":"sec-edgar","filing":"0001520262-26-000109","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000109/form4.xml","form_type":"4"}},{"id":714560,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-07-06T20:48:01.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":54.03,"value":109897.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":227490,"source":{"system":"sec-edgar","filing":"0001520262-26-000105","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000105/form4.xml","form_type":"4"}},{"id":720765,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are fully vested in accordance with their terms."}],"balance_after":1356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720764,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":700,"price":52.1314,"value":36491.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.10 to $52.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":73389,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720763,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":8300,"price":51.4613,"value":427128.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.06 to $52.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":74089,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720762,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":82389,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":739272,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-06-13T00:04:20.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":45.1,"value":90200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/11/2026."}],"balance_after":25680,"source":{"system":"sec-edgar","filing":"0001520262-26-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000101/form4.xml","form_type":"4"}},{"id":749279,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-06-04T21:00:14.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":43.05,"value":87563.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":229524,"source":{"system":"sec-edgar","filing":"0001520262-26-000099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000099/form4.xml","form_type":"4"}},{"id":756759,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":6356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":756758,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":41.6715,"value":375043.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.37 to $42.19. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":77389,"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":756757,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":86389,"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":758473,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-29T22:03:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":12825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":12826,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":12825},"source":{"system":"sec-edgar","filing":"0001520262-26-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/form4.xml","form_type":"4"}},{"id":758472,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-29T22:03:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":3392,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":3394,"derivative":{"exercise_price":20.03,"expiration_date":"2030-02-20","underlying":"Ordinary Shares","underlying_shares":3392},"source":{"system":"sec-edgar","filing":"0001520262-26-000095","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/form4.xml","form_type":"4"}},{"id":758471,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Ordinary Shares","published_at":"2026-05-29T22:03:13.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":16217,"price":42.3634,"value":687007.2578,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.245 to $42.50. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":7717,"source":{"system":"sec-edgar","filing":"0001520262-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/form4.xml","form_type":"4"}},{"id":758470,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Ordinary Shares","published_at":"2026-05-29T22:03:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":12825,"price":19.34,"value":248035.5,"ownership":{"direct":true},"balance_after":23934,"source":{"system":"sec-edgar","filing":"0001520262-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/form4.xml","form_type":"4"}},{"id":758469,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Ordinary Shares","published_at":"2026-05-29T22:03:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":3392,"price":20.03,"value":67941.76,"ownership":{"direct":true},"balance_after":11109,"source":{"system":"sec-edgar","filing":"0001520262-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000095/form4.xml","form_type":"4"}},{"id":765467,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:08:26.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000093/form4.xml","form_type":"4"}},{"id":765466,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:08:26.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000093/form4.xml","form_type":"4"}},{"id":765465,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:08:26.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000093/form4.xml","form_type":"4"}},{"id":765464,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:08:26.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":27680,"source":{"system":"sec-edgar","filing":"0001520262-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000093/form4.xml","form_type":"4"}},{"id":765463,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38587,"kind":"person","name":"Wright Christopher I","position":1,"cik":"0001838503","reported_name":"Wright Christopher I","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:08:26.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":29155,"source":{"system":"sec-edgar","filing":"0001520262-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000093/form4.xml","form_type":"4"}},{"id":765866,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44704,"kind":"person","name":"Wilson Frank Anders","position":1,"cik":"0001462948","reported_name":"Wilson Frank Anders","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:06:47.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1462948/000152026226000092/form4.xml","form_type":"4"}},{"id":765865,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44704,"kind":"person","name":"Wilson Frank Anders","position":1,"cik":"0001462948","reported_name":"Wilson Frank Anders","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:06:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462948/000152026226000092/form4.xml","form_type":"4"}},{"id":765864,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44704,"kind":"person","name":"Wilson Frank Anders","position":1,"cik":"0001462948","reported_name":"Wilson Frank Anders","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:06:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462948/000152026226000092/form4.xml","form_type":"4"}},{"id":765863,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44704,"kind":"person","name":"Wilson Frank Anders","position":1,"cik":"0001462948","reported_name":"Wilson Frank Anders","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:06:47.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":35751,"source":{"system":"sec-edgar","filing":"0001520262-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462948/000152026226000092/form4.xml","form_type":"4"}},{"id":765862,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44704,"kind":"person","name":"Wilson Frank Anders","position":1,"cik":"0001462948","reported_name":"Wilson Frank Anders","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:06:47.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":37226,"source":{"system":"sec-edgar","filing":"0001520262-26-000092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462948/000152026226000092/form4.xml","form_type":"4"}},{"id":765462,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:04:37.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000091/form4.xml","form_type":"4"}},{"id":765461,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:04:37.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000091/form4.xml","form_type":"4"}},{"id":765460,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:04:37.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000091","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000091/form4.xml","form_type":"4"}},{"id":765459,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:04:37.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":15395,"source":{"system":"sec-edgar","filing":"0001520262-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000091/form4.xml","form_type":"4"}},{"id":765458,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":27121,"kind":"person","name":"snyderman nancy lynn MD","position":1,"cik":"0001675198","reported_name":"snyderman nancy lynn MD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:04:37.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":16870,"source":{"system":"sec-edgar","filing":"0001520262-26-000091","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000091/form4.xml","form_type":"4"}},{"id":765619,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38418,"kind":"person","name":"MCKEON BRIAN P","position":1,"cik":"0001219445","reported_name":"MCKEON BRIAN P","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:03:35.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1219445/000152026226000090/form4.xml","form_type":"4"}},{"id":765618,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38418,"kind":"person","name":"MCKEON BRIAN P","position":1,"cik":"0001219445","reported_name":"MCKEON BRIAN P","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:03:35.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1219445/000152026226000090/form4.xml","form_type":"4"}},{"id":765617,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38418,"kind":"person","name":"MCKEON BRIAN P","position":1,"cik":"0001219445","reported_name":"MCKEON BRIAN P","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:03:35.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1219445/000152026226000090/form4.xml","form_type":"4"}},{"id":765616,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38418,"kind":"person","name":"MCKEON BRIAN P","position":1,"cik":"0001219445","reported_name":"MCKEON BRIAN P","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:03:35.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":38536,"source":{"system":"sec-edgar","filing":"0001520262-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219445/000152026226000090/form4.xml","form_type":"4"}},{"id":765615,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":38418,"kind":"person","name":"MCKEON BRIAN P","position":1,"cik":"0001219445","reported_name":"MCKEON BRIAN P","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:03:35.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":40011,"source":{"system":"sec-edgar","filing":"0001520262-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219445/000152026226000090/form4.xml","form_type":"4"}},{"id":765843,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765842,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765841,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765840,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":18222,"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765839,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:01:54.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":19697,"source":{"system":"sec-edgar","filing":"0001520262-26-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000089/form4.xml","form_type":"4"}},{"id":765835,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44698,"kind":"person","name":"LAURENCIN CATO T","position":1,"cik":"0001444810","reported_name":"LAURENCIN CATO T","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:00:52.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444810/000152026226000088/form4.xml","form_type":"4"}},{"id":765834,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44698,"kind":"person","name":"LAURENCIN CATO T","position":1,"cik":"0001444810","reported_name":"LAURENCIN CATO T","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-23T00:00:52.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444810/000152026226000088/form4.xml","form_type":"4"}},{"id":765833,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44698,"kind":"person","name":"LAURENCIN CATO T","position":1,"cik":"0001444810","reported_name":"LAURENCIN CATO T","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-23T00:00:52.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444810/000152026226000088/form4.xml","form_type":"4"}},{"id":765832,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44698,"kind":"person","name":"LAURENCIN CATO T","position":1,"cik":"0001444810","reported_name":"LAURENCIN CATO T","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:00:52.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":33769,"source":{"system":"sec-edgar","filing":"0001520262-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444810/000152026226000088/form4.xml","form_type":"4"}},{"id":765831,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44698,"kind":"person","name":"LAURENCIN CATO T","position":1,"cik":"0001444810","reported_name":"LAURENCIN CATO T","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-23T00:00:52.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":35244,"source":{"system":"sec-edgar","filing":"0001520262-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444810/000152026226000088/form4.xml","form_type":"4"}},{"id":765457,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T23:59:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000087","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765456,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T23:59:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000087","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000087/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765450,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T23:58:06.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":5409,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000086","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765449,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T23:58:06.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to reflect the vesting terms applicable to this award, which were reported incorrectly on the original Form 4. The correct vesting schedule is set forth in Footnote 1 above."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000086","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000086/form4a.xml","form_type":"4/A","original_submission_date":"2026-05-22"}},{"id":765455,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765454,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."}],"balance_after":5409,"derivative":{"exercise_date":"2027-05-20","underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765453,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the stock option award vest and become exercisable in full on 5/20/2027."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765452,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1475,"price":36.95,"value":54501.25,"ownership":{"direct":true},"balance_after":35751,"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765451,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":31955,"kind":"person","name":"GAYNOR RICHARD","position":1,"cik":"0001741284","reported_name":"GAYNOR RICHARD","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:59:13.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":37226,"source":{"system":"sec-edgar","filing":"0001520262-26-000084","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000084/form4.xml","form_type":"4"}},{"id":765447,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6142},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765446,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":5409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in full on 5/20/2027."}],"balance_after":5409,"derivative":{"exercise_date":"2027-05-20","underlying":"Ordinary Shares","underlying_shares":5409},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765445,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Non Qualified Stock Option (Right to Buy)","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the stock option award vest and become exercisable in full on 5/20/2027."}],"balance_after":11538,"derivative":{"exercise_price":36.98,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Ordinary Shares","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765444,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3207,"price":36.95,"value":118498.65,"ownership":{"direct":true},"balance_after":106679,"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":765443,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44623,"kind":"person","name":"Cooke Shane","position":1,"cik":"0001524823","reported_name":"Cooke Shane","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:57:44.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":6142,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":109886,"source":{"system":"sec-edgar","filing":"0001520262-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000083/form4.xml","form_type":"4"}},{"id":793566,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-05-05T00:42:36.000Z","date":"2026-05-04","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":33.2,"value":67528.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":231558,"source":{"system":"sec-edgar","filing":"0001520262-26-000074","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000074/form4.xml","form_type":"4"}},{"id":795333,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":11356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":795332,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":33.3955,"value":300559.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.21 to $33.49. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":81389,"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":795331,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":90389,"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":809613,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Restricted Stock Unit Award","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"exercise","planned":false,"acquired":false,"shares":3751,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in three equal annual installments commencing on 4/11/2025."}],"balance_after":3752,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3751},"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":809612,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":901,"price":33.36,"value":30057.36,"ownership":{"direct":true},"balance_after":13555,"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":809611,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2026-04-13T21:09:47.000Z","date":"2026-04-11","kind":"exercise","planned":false,"acquired":true,"shares":3751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":14456,"source":{"system":"sec-edgar","filing":"0001520262-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000152026226000070/form4.xml","form_type":"4"}},{"id":814271,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":2393,"kind":"person","name":"Gaffin David Joseph","position":1,"cik":"0001675905","reported_name":"Gaffin David Joseph","relationship":{"officer":true,"officer_title":"EVP, CLO, Alkermes, Inc."}}],"security":"Ordinary Shares","published_at":"2026-04-06T23:56:39.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":2034,"price":34.57,"value":70315.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025."}],"balance_after":233592,"source":{"system":"sec-edgar","filing":"0001520262-26-000067","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000067/form4.xml","form_type":"4"}},{"id":822584,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":16356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":822583,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":35.5116,"value":319604.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.50 to $35.62. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":85389,"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":822582,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":94389,"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":861679,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":32144,"kind":"person","name":"Reed Joshua","position":1,"cik":"0001746541","reported_name":"Reed Joshua","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-03-05T01:21:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":30854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."}],"balance_after":30854,"derivative":{"underlying":"Ordinary Shares","underlying_shares":30854},"source":{"system":"sec-edgar","filing":"0001520262-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746541/000152026226000063/form4.xml","form_type":"4"}},{"id":861678,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":32144,"kind":"person","name":"Reed Joshua","position":1,"cik":"0001746541","reported_name":"Reed Joshua","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T01:21:27.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":66430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027."}],"balance_after":66430,"derivative":{"exercise_price":30.25,"expiration_date":"2036-03-02","underlying":"Ordinary Shares","underlying_shares":66430},"source":{"system":"sec-edgar","filing":"0001520262-26-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746541/000152026226000063/form4.xml","form_type":"4"}},{"id":862621,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2026-03-05T01:20:22.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":88843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition."}],"balance_after":88843,"derivative":{"underlying":"Ordinary Shares","underlying_shares":88843},"source":{"system":"sec-edgar","filing":"0001520262-26-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000152026226000062/form4.xml","form_type":"4"}},{"id":860896,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Restricted Stock Unit Award","published_at":"2026-03-05T01:19:23.000Z","date":"2026-03-02","kind":"grant","planned":true,"acquired":true,"shares":14176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."}],"balance_after":14176,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14176},"source":{"system":"sec-edgar","filing":"0001520262-26-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000061/form4.xml","form_type":"4"}},{"id":860895,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43119,"kind":"person","name":"Parisi Samuel Joseph","position":1,"cik":"0002010945","reported_name":"Parisi Samuel Joseph","relationship":{"officer":true,"officer_title":"VP, Finance (Interim PAO)"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T01:19:23.000Z","date":"2026-03-02","kind":"grant","planned":true,"acquired":true,"shares":15033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027."}],"balance_after":15033,"derivative":{"exercise_price":30.25,"expiration_date":"2036-03-02","underlying":"Ordinary Shares","underlying_shares":15033},"source":{"system":"sec-edgar","filing":"0001520262-26-000061","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000061/form4.xml","form_type":"4"}}],"next_cursor":"2026-03-05T01:19:23.000000Z,860895"}